Data / Research funding / Minnesota / Recombinetics, Inc.
Recombinetics, Inc.: 3 NIH awards ($2.5M), fiscal years 2021 to 2026
Recombinetics, Inc. in Eagan, MN is funded under 3 NIH awards ($2.5M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- L99NWZNZ7K57
- State
- Minnesota
Awards
3 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| SCGE Disease Models Studies Supplement: Evaluation of prime editing for the amelioration of alpha-1-antitrypsin deficiency in murine and porcine models. | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $1,724,497 | September 20, 2018 | July 31, 2024 | CARLSON, DANIEL FRED | reporter.nih.gov |
| Gene Therapy for MPS IV A in a Novel Porcine Model of the Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $384,999 | September 18, 2024 | August 31, 2025 | CAMPBELL, JARRYD MATTHEW | reporter.nih.gov |
| An Inducible Swine Hepatocellular Carcinoma Platform for Enhanced Therapeutic Development | NIH | National Cancer Institute | 2023 | $342,154 | September 1, 2023 | January 8, 2025 | KORPELA, DEREK MATTHEW | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2024 | 1 | $384,999 | 0 | $0 |
| 2023 | 1 | $342,154 | 0 | $0 |
| 2022 | 1 | $943,024 | 0 | $0 |
| 2021 | 1 | $781,473 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) | PAR-24-279 | NIH | 93.846 | November 2, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) | PAR-24-280 | NIH | 93.846 | November 2, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.395 | November 2, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) | RFA-OD-27-009 | NIH | 93.310 | November 10, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) | RFA-RM-27-024 | NIH | 93.310 | November 10, 2026 | $100,000 | Same assistance listing 93.310 as 1 award here |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | PAR-26-152 | NIH | 93.395 | November 11, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.310 | November 16, 2026 | $50,000 | Same assistance listing 93.310 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.310 | November 18, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.310 | November 18, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.395 | November 20, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.846 | November 23, 2026 | $375,000 | Same assistance listing 93.846 as 1 award here |
| Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) | RFA-RM-27-007 | NIH | 93.310 | November 23, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) | RFA-RM-27-016 | NIH | 93.310 | November 23, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) | RFA-RM-27-025 | NIH | 93.310 | November 23, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.310 | November 24, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0 | RFA-AR-26-006 | NIH | 93.846 | December 1, 2026 | Not listed | Same assistance listing 93.846 as 1 award here |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | RFA-OD-27-008 | NIH | 93.310 | December 2, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.310 | December 4, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.846 | January 5, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.846 | January 5, 2027 | Not listed | Same assistance listing 93.846 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.